Relay Therapeutics | 10-Q: Quarterly report
Relay Therapeutics | 8-K: Relay Therapeutics Reports First Quarter 2024 Financial Results and Corporate Highlights
Relay Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rahmer Peter
Relay Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Adams Brian
Relay Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Catinazzo Thomas
Relay Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Bergstrom Donald A
Relay Therapeutics | ARS: Annual Report to Security Holders
Relay Therapeutics | DEFA14A: Others
Relay Therapeutics | DEF 14A: Definitive information statements
Relay Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Adams Brian
Relay Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rahmer Peter
Relay Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Bergstrom Donald A
Relay Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Catinazzo Thomas
Relay Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Relay Therapeutics | 10-K: Annual report
Relay Therapeutics | 8-K: Relay Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights
Relay Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Casdin Capital, LLC(5.99%),Eli Casdin(5.99%), etc.
Relay Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-T. ROWE PRICE ASSOCIATES, INC.(7.0%)
Relay Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(8.64%)
Relay Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rahmer Peter
No Data